ARTICLE | Clinical News
Testosterone tablet: Phase III
November 19, 2001 8:00 AM UTC
In a 66-patient European Phase III trial comparing its testosterone buccal tablet to Andropatch from GlaxoSmithKline plc (GSK, LSE:GSK, London, U.K.), COB's buccal tablet gave testosterone levels wit...